The Effects of Long-Term Testosterone Use on Lipid-Related Cardiovascular Risk Factors Among FtM Patients

International Journal of Transgenderism

Volumn 15, Issue , 2014, Pages 164-172

  Goodrum, Benjamin A ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

Author keywords

cardiovascular; cross sex hormone; female to male; gender dysphoria; Testosterone; trans*; transgender

Indexed keywords

EID: 84924354097     PISSN: 15532739     EISSN: 14344599     Source Type: Journal    
DOI: 10.1080/15532739.2014.995261     Document Type: Review

References (31)

1. Alegria, C. A. (2011). Transgender identity and health care: Implications for psychosocial and physical evaluation. Journal of the American Academy of Nurse Practitioners, 23(4), 175–182. doi:10.1111/j.1745-7599.2010.00595.x; 10.1111/j.1745-7599.2010.00595.x
2. American Heart Association. (2013). Lifestyle changes. Retrieved from http://www.heart.org/HEARTORG/Conditions/HeartAttack/PreventionTreatmentofHeartAttack/Lifedebstyle-Changes_UCM_303934_Article.jsp
3. Asscheman, H., Giltay, E. J., Megens, J. A., de Ronde, W. P., van Trotsenburg, M. A., & Gooren, L. J. (2011). A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology/European Federation of Endocrine Societies, 164(4), 635–642. doi:10.1530/EJE-10-1038; 10.1530/EJE-10-1038
4. Bazarra-Castro, M. A., Sievers, C., Fulda, S., Ettmeier, W., Klotsche, J., Pieper, V., … Stalla, G. K. (2009). Comorbidities in transsexual patients under hormonal treatment in comparison with a control group sampled from the DETECT-cohort. Experimental and Clinical Endocrinology & Diabetes, 117(10), 660–661.
5. Bockting, W., Coleman, E., & De Cuypere, G. (2011). Care of transsexual persons [Author reply 2560]. New England Journal of Medicine, 364(26), 2559–2560. doi:10.1056/NEJMc1104884#SA1; 10.1056/NEJMc1104884#SA1
6. Chandra, P., Basra, S. S., Chen, T. C., & Tangpricha, V. (2010). Alterations in lipids and adipocyte hormones in female-to-male transsexuals. International Journal of Endocrinology, 2010. doi:10.1155/2010/945053
7. Deutsch, M. B., & Feldman, J. L. (2013). Updated recommendations from the world professional association for transgender health standards of care. American Family Physician, 87(2), 89–93.
8. Elamin, M. B., Garcia, M. Z., Murad, M. H., Erwin, P. J., & Montori, V. M. (2010). Effect of sex steroid use on cardiovascular risk in transsexual individuals: A systematic review and meta-analyses. Clinical Endocrinology, 72(1), 1–10. doi:10.1111/j.1365-2265.2009.03632.x; 10.1111/j.1365-2265.2009.03632.x
9. Glaser, R., & Dimitrakakis, C. (2013). Testosterone therapy in women: Myths and misconceptions. Maturitas, 74(3), 230–234. doi:10.1016/j.maturitas.2013.01.003; 10.1016/j.maturitas.2013.01.003
10. Gooren, L. J., & Giltay, E. J. (2008). Review of studies of androgen treatment of female-to-male transsexuals: Effects and risks of administration of androgens to females. Journal of Sexual Medicine, 5(4), 765–776. doi:10.1111/j.1743-6109.2007.00646.x
11. Gooren, L.J., & Traish, A.M. (2010). Safety of physiological testosterone therapy in women: Lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy. Journal of Sexual Medicine, 4(5), 3758–3764. doi:10.1111/j.1743-6109.2010.01962.x
12. Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011). GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology. Journal Of Clinical Epidemiology, 64(4), 380–382. doi:10.1016/j.jclinepi.2010.09.011
13. Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., III, Spack, N. P., … Endocrine Society. (2009). Endocrine treatment of transsexual persons: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 94(9), 3132–3154. doi:10.1210/jc.2009-0345; 10.1210/jc.2009-0345
14. Jacobeit, J. W., Gooren, L. J., & Schulte, H. M. (2007). Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. Journal of Sexual Medicine, 4(5), 1479–1484. doi: 10.1111/j.1743-6109.2007.00556.x
15. Jacobeit, J. W., Gooren, L. J., & Schulte, H. M. (2009). Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals. European Journal of Endocrinology, 161(5), 795–798. doi:10.1530/EJE-09-0412
16. Jenner, C. O. (2010). Transsexual primary care. Journal of the American Academy of Nurse Practitioners, 22(8), 403–408. doi:10.1111/j.1745-7599.2010.00532.x; 10.1111/j.1745-7599.2010.00532.x
17. Jonsen, A. R., Siegler, M., & Winslade, W. J. (2010). Clinical ethics: A practical approach to ethical decisions in clinical medicine (7th ed.) [Access Medicine version]. Retrieved from http://accessmedicine.mhmedical.com/book.aspx?bookID=364
18. Kanaya, A. M., & Vaisse, C. (2011). Obesity. In D. Gardner & D. Shoback (Eds.), Greenspan's basic and clinical endocrinology [Access Medicine version]. Retrieved from http://accessmedicine.mhmedical.com/book.aspx?bookID=380
19. Kitzman, D. W., & Taffet, G. (2009). Effects of aging on cardiovascular structure and function. In J. B. Halter, J. G. Ouslander, M. E. Tinetti, S. Studenski, K. P. High, S. Asthana (Eds.), Hazzard's Geriatric Medicine and Gerontology [Access Medicine version]. Retrieved from http://www.accessmedicine.com/content.aspx?aID=5124284
20. Knezevich, E. L., Viereck, L. K., & Drincic, A. T. (2012). Medical management of adult transsexual persons. Pharmacotherapy, 32(1), 54–66. doi:10.1002/PHAR.1006; 10.1002/PHAR.1006
21. Meriggiola, M. C., & Berra, M. (2012). Long-term cross-sex hormone treatment is safe in transsexual subjects. Asian Journal of Andrology, 14(6), 813–814. doi:10.1038/aja.2012.89; 10.1038/aja.2012.89
22. Moore, E., Wisniewski, A., & Dobs, A. (2003). Endocrine treatment of transsexual people: A review of treatment regimens, outcomes, and adverse effects. The Journal of Clinical Endocrinology and Metabolism, 88(8), 3467–3473. doi:10.1210/jc.2002-021967
23. Mueller, A., Kiesewetter, F., Binder, H., Beckmann, M. W., & Dittrich, R. (2007). Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. The Journal of Clinical Endocrinology and Metabolism, 92(9), 3470–3475. doi:jc.2007-0746
24. Ott, J., Aust, S., Promberger, R., Huber, J. C., & Kaufmann, U. (2011). Cross-sex hormone therapy alters the serum lipid profile: A retrospective cohort study in 169 transsexuals. Journal of Sexual Medicine, 8(8), 2361–2369. doi:10.1111/j.1743-6109.2011.02311.x; 10.1111/j.1743-6109.2011.02311.x
25. Rosser, B. R. S., Oakes, J. M., Bockting, W. O., & Miner, M. (2007). Capturing the social demographics of hidden sexual minorities: An internet study of the transgender population in the United States. Sexuality Research & Social Policy: A Journal of the NSRC, 4(2), 50–64. doi:http://dx.doi.org/10.1525/srsp.2007.4.2.50
26. Sobralske, M. (2005). Primary care needs of patients who have undergone gender reassignment. Journal of the American Academy of Nurse Practitioners, 17(4), 133–138. doi:10.111/j.1041-2972.2005.0021.x
27. Spack, N. P. (2013). Management of transgenderism. JAMA: Journal of the American Medical Association, 309(5), 478–484. doi:10.1001/jama.2012.165234; 10.1001/jama.2012.165234
28. Steinle, K. (2011). Hormonal management of the female-to-male transgender patient. Journal of Midwifery & Women's Health, 56(3), 293–302. doi:10.1111/j.1542-2011.2011.00037.x; 10.1111/j.1542-2011.2011.00037.x
29. Traish, A. M., & Gooren, L. J. (2010). Safety of physiological testosterone therapy in women: Lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy. Journal of Sexual Medicine, 7(11), 3758–3764. doi:10.1111/j.1743-6109.2010.01962.x; 10.1111/j.1743-6109.2010.01962.x
30. Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., & T’Sjoen, G. (2012). Long-term evaluation of cross-sex hormone treatment in transsexual persons. Journal of Sexual Medicine, 9(10), 2641–2651. doi:10.1111/j.1743-6109.2012.02876.x; 10.1111/j.1743-6109.2012.02876.x
31. Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006). Androgen therapy in women: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 91(10), 3697–3710. doi:jc.2006-1121